“Down syndrome: an insight of the disease”

[1]  F. Conversano,et al.  Sonographic markers for early diagnosis of fetal malformations. , 2013, World journal of radiology.

[2]  D. Harold,et al.  Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome , 2013, Neurobiology of Aging.

[3]  K. Nicolaides,et al.  Meta‐analysis of second‐trimester markers for trisomy 21 , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  S. Phadke,et al.  Multiplex quantitative fluorescent polymerase chain reaction for detection of aneuploidies. , 2012, Genetic testing and molecular biomarkers.

[5]  D. Halley,et al.  Multiplex ligation-depending probe amplification is not suitable for detection of low-grade mosaicism , 2011, European Journal of Human Genetics.

[6]  C. Ballard,et al.  An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome , 2010, International journal of Alzheimer's disease.

[7]  S. Phadke,et al.  Diagnosis of Down syndrome and detection of origin of nondisjunction by short tandem repeat analysis. , 2010, Genetic testing and molecular biomarkers.

[8]  K. McKernan,et al.  Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. , 2010, Clinical chemistry.

[9]  K. Gardiner.  Molecular basis of pharmacotherapies for cognition in Down syndrome. , 2010, Trends in pharmacological sciences.

[10]  R. Urbano.  Health Issues Among Persons with Down Syndrome , 2010 .

[11]  Z. Alfirevic,et al.  Update on Procedure-Related Risks for Prenatal Diagnosis Techniques , 2009, Fetal Diagnosis and Therapy.

[12]  Franck Sturtz,et al.  The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome , 2009, Genetics in Medicine.

[13]  M. Gerstein,et al.  The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies , 2009, Proceedings of the National Academy of Sciences.

[14]  S. Antonarakis,et al.  Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21 , 2009, European Journal of Human Genetics.

[15]  K. Voelkerding,et al.  Next-generation sequencing: from basic research to diagnostics. , 2009, Clinical chemistry.

[16]  G. Daniels,et al.  Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects , 2009, Prenatal diagnosis.

[17]  K. Anderson,et al.  Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. , 2009, Blood.

[18]  C. Wright,et al.  The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. , 2008, Human reproduction update.

[19]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[20]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[21]  E. Mardis.  The impact of next-generation sequencing technology on genetics. , 2008, Trends in genetics : TIG.

[22]  C. Ding,et al.  Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. , 2008, Clinical chemistry.

[23]  Praveen Sethupathy,et al.  Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. , 2007, American journal of human genetics.

[24]  M. Delorenzi,et al.  Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. , 2007, American journal of human genetics.

[25]  D. Maddocks,et al.  Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast , 2007, Prenatal diagnosis.

[26]  G. Avalos,et al.  The prevalence of Down syndrome in County Galway. , 2007, Irish medical journal.

[27]  D. Patterson.  Genetic mechanisms involved in the phenotype of Down syndrome. , 2007, Mental retardation and developmental disabilities research reviews.

[28]  Sabita K. Murthy,et al.  Incidence of Down Syndrome in Dubai, UAE , 2006, Medical Principles and Practice.

[29]  Lora J. H. Bean,et al.  CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome , 2006, American journal of medical genetics. Part A.

[30]  B. Craig.  Atrioventricular septal defect: from fetus to adult , 2006, Heart.

[31]  Russell S Kirby,et al.  National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[32]  Ahmad Salehi,et al.  Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.

[33]  K. Davies,et al.  RCAN1 (DSCR1 or Adapt78) * stimulates expression of GSK‐3β , 2006, The FEBS journal.

[34]  A. Bener,et al.  The incidence patterns of Down syndrome in Qatar , 2006, Clinical genetics.

[35]  S. Edland,et al.  Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: A two-stage study , 2005, Journal of the Neurological Sciences.

[36]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[37]  N. Greene.  First-trimester sonographic screening for Down syndrome. , 2004, Obstetrics and gynecology.

[38]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[39]  J. Schouten,et al.  Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA) , 2003, Journal of medical genetics.

[40]  F. Malone,et al.  First‐Trimester Sonographic Screening for Down Syndrome , 2003, Obstetrics and gynecology.

[41]  N. Roizen,et al.  Down's syndrome , 2003, The Lancet.

[42]  C. Maslen,et al.  Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. , 2003, American journal of human genetics.

[43]  R. Hussain,et al.  The changing survival profile of people with Down's syndrome: implications for genetic counselling , 2002, Clinical genetics.

[44]  M. L. Beau,et al.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome , 2002, Nature Genetics.

[45]  R. Glanville,et al.  Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. , 2002, Gene.

[46]  A. Benachi,et al.  New strategy for prenatal diagnosis of X-linked disorders. , 2002, The New England journal of medicine.

[47]  C. Draheim,et al.  Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. , 2002, American journal of mental retardation : AJMR.

[48]  S. Lyonnet,et al.  Hirschsprung disease, associated syndromes, and genetics: a review , 2001, Journal of medical genetics.

[49]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[50]  F. Huppert,et al.  Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. , 2001, Journal of intellectual disability research : JIDR.

[51]  E. Green,et al.  Detailed mapping of a congenital heart disease gene in chromosome 3p25 , 2000, Journal of medical genetics.

[52]  A. Dalton,et al.  Prevalence of dementia and impact on intellectual disability services. , 2000, Mental retardation.

[53]  H. Hasle,et al.  Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.

[54]  C. Sismani,et al.  Measurement of locus copy number by hybridisation with amplifiable probes. , 2000, Nucleic acids research.

[55]  I. Torres,et al.  Congenital anomalies of the small intestine, colon, and rectum. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[56]  E. Hook,et al.  International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age , 1999, Journal of medical genetics.

[57]  N. Wald,et al.  Fetal loss in Down syndrome pregnancies , 1999, Prenatal diagnosis.

[58]  I. Kola,et al.  The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. , 1999, Journal of neural transmission. Supplementum.

[59]  C. Torfs,et al.  Anomalies in Down syndrome individuals in a large population-based registry. , 1998, American journal of medical genetics.

[60]  F. Huppert,et al.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome , 1998, British Journal of Psychiatry.

[61]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[62]  S. Orkin,et al.  A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development , 1997, The EMBO journal.

[63]  V. Sheffield,et al.  Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. , 1997, Human molecular genetics.

[64]  J. Brown,et al.  Low blood pressure in Down's syndrome, A link with Alzheimer's disease? , 1996, Hypertension.

[65]  P. Johannsen,et al.  The prevalence of dementia in Down syndrome. , 1996, Dementia.

[66]  K. Tashiro,et al.  A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21. , 1996, Genomics.

[67]  J. Delabar,et al.  Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[68]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.

[69]  W. Kuo,et al.  Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. , 1991, American journal of human genetics.

[70]  R. S. Williams,et al.  A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.

[71]  A. Rimm,et al.  Transplant or chemotherapy in acute myelogenous leukaemia , 1989 .

[72]  B. L. Shapiro,et al.  Down syndrome--a disruption of homeostasis. , 1983, American journal of medical genetics.

[73]  F. Conte,et al.  Practical and theoretical implications of fetal-maternal lymphocyte transfer. , 1969, Lancet.

[74]  R. Good,et al.  Simultaneous occurrence of mongolism and leukemia; report of a nationwide survey. , 1957, A.M.A. journal of diseases of children.

[75]  F. Stumpf,et al.  Acute Lymphatic Leukemia: Report of a Case* , 1938 .